Abstract

Compound acquisition has always been a very important component in the discovery and development of new biologically active entities. With the rapid advances in high throughput screening coupled with the ever-decreasing time requirements for the discovery phase, the number and quality of compounds screened is of great importance. This presentation will discuss some of the techniques and processes that can be used in compound acquisition.